Added On : 21st November 2011A meta-analysis supports evidence of increased risk for GI bleeding from low-dose aspirin alone and in combination with clopidogrel or anticoagulants.
Aspirin in low doses (75–325 mg/day) is commonly used as secondary prophylaxis after cardiovascular thrombotic events. However, its value for primary prophylaxis is unclear because of evidence that it increases the risk for gastrointestinal bleeding.
Added On : 21st November 2011A meta-analysis supports evidence of increased risk for GI bleeding from low-dose aspirin alone and in combination with clopidogrel or anticoagulants.
Aspirin in low doses (75–325 mg/day) is commonly used as secondary prophylaxis after cardiovascular thrombotic events. However, its value for primary prophylaxis is unclear because of evidence that it increases the risk for gastrointestinal bleeding.
Added On : 4th December 2011Aspirin 600 mg Daily Reduced Cancers in Lynch Syndrome
Patients randomized to aspirin for 2 years had about half the risk for colorectal cancer as a placebo group.
New findings on the chemopreventive effects of aspirin are now available from a randomized, controlled study — the first to use cancer as the study endpoint.
Added On : 12th January 2012Better Adherence to CT Colonography Might Not Trump Colonoscopy Advantages
In a randomized, controlled trial in the Netherlands, adherence to CT colonography was higher than to colonoscopy for colorectal cancer screening, but results might not be generalizable to the U.S.
Added On : 26th January 2012People who had undergone adenoma removal had a higher risk for colorectal cancer than the general population.
Studies estimating the risk for colorectal cancer in patients who have undergone adenoma removal versus the general population have yielded widely discordant results. These discrepancies can sometimes be explained by variability in patient eligibility requirements, types of follow-up, and source populations.
Added On : 9th February 2012A review of published research worldwide showed increasing incidence of both Crohn disease and ulcerative colitis but lacked data from developing countries.
To summarize worldwide data on the incidence and prevalence of inflammatory bowel disease (IBD) — which comprises ulcerative colitis (UC) and Crohn disease (CD) — researchers systematically reviewed 238 incidence and 122 prevalence studies. The highest percentage of studies came from Europe, the second highest from Asia and the Middle East, and the third highest from North America.